Table 3 Comparison of clinical outcome between normal and elevated Qalb groups of neuronal surface antibody-associated autoimmune encephalitis
From: Evaluation of CSF albumin quotient in neuronal surface antibody-associated autoimmune encephalitis
Total (n = 93) | Normal Qalb group (n = 60) | Elevated Qalb group (n = 33) | P value | |
|---|---|---|---|---|
First-line immunotherapies, n (%) | ||||
Steroids | 80 (86.0) | 54 (90.0) | 26 (78.8) | 0.238 |
IVIG | 74 (79.6) | 50 (83.3) | 24 (72.7) | 0.225 |
The mRS at discharge, median (IQR) | 1.0 (1.0, 2.0) | 1.0 (1.0, 2.0) | 2.0 (1.0, 3.0) | 0.024 |
Follow-up time, years, median (IQR) | 2.7 (1.6, 4.6) | 2.6 (1.6, 4.4) | 3.8 (2.0, 5.0) | 0.253 |
The mRS at last follow-up, median (IQR) | 1.0 (0.0, 2.0) | 1.0 (0.0, 1.0) | 1.0 (0.5, 2.0) | 0.021 |